176 related articles for article (PubMed ID: 23153292)
1. Spatial morphological and molecular differences within solid tumors may contribute to the failure of vascular disruptive agent treatments.
Nguyen L; Fifis T; Malcontenti-Wilson C; Chan LS; Costa PN; Nikfarjam M; Muralidharan V; Christophi C
BMC Cancer; 2012 Nov; 12():522. PubMed ID: 23153292
[TBL] [Abstract][Full Text] [Related]
2. Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor.
Fifis T; Nguyen L; Malcontenti-Wilson C; Chan LS; Nunes Costa PL; Daruwalla J; Nikfarjam M; Muralidharan V; Waltham M; Thompson EW; Christophi C
Cancer Med; 2013 Oct; 2(5):595-610. PubMed ID: 24403226
[TBL] [Abstract][Full Text] [Related]
3. Vascular disruptive agent OXi4503 and anti-angiogenic agent Sunitinib combination treatment prolong survival of mice with CRC liver metastasis.
Nguyen L; Fifis T; Christophi C
BMC Cancer; 2016 Jul; 16():533. PubMed ID: 27460820
[TBL] [Abstract][Full Text] [Related]
4. Vascular targeting agent Oxi4503 inhibits tumor growth in a colorectal liver metastases model.
Malcontenti-Wilson C; Chan L; Nikfarjam M; Muralidharan V; Christophi C
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e96-e104. PubMed ID: 17559382
[TBL] [Abstract][Full Text] [Related]
5. Effect of vascular targeting agent Oxi4503 on tumor cell kinetics in a mouse model of colorectal liver metastasis.
Chan LS; Malcontenti-Wilson C; Muralidharan V; Christophi C
Anticancer Res; 2007; 27(4B):2317-23. PubMed ID: 17695520
[TBL] [Abstract][Full Text] [Related]
6. Alterations in vascular architecture and permeability following OXi4503 treatment.
Chan LS; Malcontenti-Wilson C; Muralidharan V; Christophi C
Anticancer Drugs; 2008 Jan; 19(1):17-22. PubMed ID: 18043126
[TBL] [Abstract][Full Text] [Related]
7. Combretastatin family member OXI4503 induces tumor vascular collapse through the induction of endothelial apoptosis.
Sheng Y; Hua J; Pinney KG; Garner CM; Kane RR; Prezioso JA; Chaplin DJ; Edvardsen K
Int J Cancer; 2004 Sep; 111(4):604-10. PubMed ID: 15239140
[TBL] [Abstract][Full Text] [Related]
8. Styrene maleic acid copolymer-pirarubicin induces tumor-selective oxidative stress and decreases tumor hypoxia as possible treatment of colorectal cancer liver metastases.
Daruwalla J; Greish K; Malcontenti-Wilson C; Muralidharan V; Maeda H; Christophi C
Surgery; 2015 Jul; 158(1):236-47. PubMed ID: 25999256
[TBL] [Abstract][Full Text] [Related]
9. Support of a free radical mechanism for enhanced antitumor efficacy of the microtubule disruptor OXi4503.
Rice L; Pampo C; Lepler S; Rojiani AM; Siemann DW
Microvasc Res; 2011 Jan; 81(1):44-51. PubMed ID: 20974154
[TBL] [Abstract][Full Text] [Related]
10. Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling.
Zhang Q; Bai X; Chen W; Ma T; Hu Q; Liang C; Xie S; Chen C; Hu L; Xu S; Liang T
Carcinogenesis; 2013 May; 34(5):962-73. PubMed ID: 23358852
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
12. Fatty Acids and a High-Fat Diet Induce Epithelial-Mesenchymal Transition by Activating TGFβ and β-Catenin in Liver Cells.
Kwapisz O; Górka J; Korlatowicz A; Kotlinowski J; Waligórska A; Marona P; Pydyn N; Dobrucki JW; Jura J; Miekus K
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525359
[TBL] [Abstract][Full Text] [Related]
13. Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition.
Xiong H; Hong J; Du W; Lin YW; Ren LL; Wang YC; Su WY; Wang JL; Cui Y; Wang ZH; Fang JY
J Biol Chem; 2012 Feb; 287(8):5819-32. PubMed ID: 22205702
[TBL] [Abstract][Full Text] [Related]
14. HIF-1α Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer.
Zhang W; Shi X; Peng Y; Wu M; Zhang P; Xie R; Wu Y; Yan Q; Liu S; Wang J
PLoS One; 2015; 10(6):e0129603. PubMed ID: 26057751
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-mesenchymal transition is necessary for acquired resistance to cisplatin and increases the metastatic potential of nasopharyngeal carcinoma cells.
Zhang P; Liu H; Xia F; Zhang QW; Zhang YY; Zhao Q; Chao ZH; Jiang ZW; Jiang CC
Int J Mol Med; 2014 Jan; 33(1):151-9. PubMed ID: 24173500
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory action of pristimerin on hypoxia‑mediated metastasis involves stem cell characteristics and EMT in PC-3 prostate cancer cells.
Zuo J; Guo Y; Peng X; Tang Y; Zhang X; He P; Li S; Wa Q; Li J; Huang S; Xu D
Oncol Rep; 2015 Mar; 33(3):1388-94. PubMed ID: 25571882
[TBL] [Abstract][Full Text] [Related]
17. Oxi4503, a novel vascular targeting agent: effects on blood flow and antitumor activity in comparison to combretastatin A-4 phosphate.
Hua J; Sheng Y; Pinney KG; Garner CM; Kane RR; Prezioso JA; Pettit GR; Chaplin DJ; Edvardsen K
Anticancer Res; 2003; 23(2B):1433-40. PubMed ID: 12820406
[TBL] [Abstract][Full Text] [Related]
18. Leukemia regression by vascular disruption and antiangiogenic therapy.
Madlambayan GJ; Meacham AM; Hosaka K; Mir S; Jorgensen M; Scott EW; Siemann DW; Cogle CR
Blood; 2010 Sep; 116(9):1539-47. PubMed ID: 20472832
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible factor 1α-induced epithelial-mesenchymal transition of endometrial epithelial cells may contribute to the development of endometriosis.
Xiong Y; Liu Y; Xiong W; Zhang L; Liu H; Du Y; Li N
Hum Reprod; 2016 Jun; 31(6):1327-38. PubMed ID: 27094478
[TBL] [Abstract][Full Text] [Related]
20. Pterostilbene, a bioactive component of blueberries, suppresses the generation of breast cancer stem cells within tumor microenvironment and metastasis via modulating NF-κB/microRNA 448 circuit.
Mak KK; Wu AT; Lee WH; Chang TC; Chiou JF; Wang LS; Wu CH; Huang CY; Shieh YS; Chao TY; Ho CT; Yen GC; Yeh CT
Mol Nutr Food Res; 2013 Jul; 57(7):1123-34. PubMed ID: 23504987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
